0% found this document useful (0 votes)
110 views33 pages

Approach To A Patient With Jaundice

The document discusses the approach to evaluating a patient presenting with jaundice. It covers the causes, types, clinical features, investigations and differential diagnosis of jaundice. Key tests include liver enzymes, bilirubin, imaging like ultrasound and biopsies for establishing the underlying etiology.

Uploaded by

Manish Adhikari
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
0% found this document useful (0 votes)
110 views33 pages

Approach To A Patient With Jaundice

The document discusses the approach to evaluating a patient presenting with jaundice. It covers the causes, types, clinical features, investigations and differential diagnosis of jaundice. Key tests include liver enzymes, bilirubin, imaging like ultrasound and biopsies for establishing the underlying etiology.

Uploaded by

Manish Adhikari
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
You are on page 1/ 33

APPROACH TO A PATIENT WITH JAUNDICE

WHAT IS JAUNDICE
• Yellowish discoloration of sclera, skin, mucous membranes due to deposition of bile
pigment

• Jaundice (icterus) is detectable clinically when the serum bilirubin is greater than 50
μmol/L (3 mg/dL).
DIFFERENTIAL ON YELLOWING OF SKIN
 CAROTENODERMA
Seen in tha patient with excessive intake of fruits and vegetables rich in carotene (carrots, squash,
peaches, oranges).

 DRUGS (QUINACREINE) : in it sclera is also involved like in jaundice.


Bilirubin metabolism
Cause for hyperbilirubinemia
1. overproduction of bilirubin

2. impaired uptake, conjugation, or excretion of bilirubin

3. regurgitation of unconjugated or conjugated bilirubin from damaged hepatocytes


or bile ducts.
HISTORY
 The onset of Jaundice in viral hepatitis is associated with a prodrome of nausea and vomiting,
malaise & myalgia.

 The onset of cholestasis is insidious, it is associated with pruritus.

 A history of fever with rigors, Rt upper abd. pain or a past history of biliary surgery suggest
cholangitis.

 Dark urine & pale stool suggest the obstructive feature.

 A history of multiple sex partners, travel, ethanol intake, drugs, bl. transfusion, needle stick
exposure & tattooing is also important.
contd...
 Previous biliary surgery with subsequent jaundice may suggest stricture, residual
stones or hepatitis.

 A family history of jaundice or liver disease suggests the possibility of hereditary


hyperbilirubinaemia or genetic disorder such as Wilson disease.
Features of types of jaundice

Hemolytic jaundice:
 Stool is high colored( due to excess stercobillinogen and stercobillin)
 Acholuric urine
 Mild jaundice (lemon yellow tinge)
 ANEMIA
 Splenomegaly
Obstructive jaundice
 Deep yellow urine ( due to presence of conjugated bilirubin)
 Stool--- pale or clay colored
 Greenish yellow tinge in bulbar conjunctiva
 Generalized pruritus
 Xanthelasma (hypercholesterolemia)
 Gall bladder may be palpable
 Rarely hepatosplenomegaly
Hepatocellular jaundice
 Urine- yellowish
 Stool – high colored
 Orange yellow tinge of bulbar conjunctiva
 Anorexia, nausea, vomiting , fever
 Tender hepatomegaly
Examination
 Patient nutritional status----- e.g temporal and proximal muscle wasting: pancreatic
ca./cirrhosis

 Enlargement of left supraclavicular LN OR Periumbilical nodes suggest abdominal


malignancy.

 Stigmata of CLD ------- jaundicde is hepatocellular in origin.

 High fever, right upper abdominal tenderness------cholangitis & choledocholithiasis.


 A systemic illness should be excluded e.g. distended jugular veins in constrictive
pericarditis or Rt. Heart Failure in patient with hepatomegaly & ascites.

 Hard nodular liver--------Primary or Secondary malignancy.

 Diffuse lymphadenopathy-----infectious mononucleosis or lymphoma.


 Rt. upper abd. scar or palpable gallbladder------Obstructive Jaundice

 Certain physical findings may suggest a particular liver disease:


 Hyperpigmentation--------haemochromatosis.
 Xanthoma-------PBC
 Kayser-Fleischer rings --------Wilson disease.
The clinical assessment & basic biochemical parameters lead
to three broad subgroups of patients:

1. Isolated elevation of s. bilirubin: when AST, ALT & ALP levels are normal.

2. Hepatocellular jaundice: when the AST & ALT levels are elevated out of
proportion to the ALP levels.

3. Cholestatic jaundice: when the ALP level is elevated out of proportion to the
AST & ALT levels.
Isolated elevation of serum Bilirubin

Unconjugated Hyperbilirubinaemia
 Increase bilirubin production (e.g. haemolysis)
 Decrease hepatocellular uptake (e.g. rifampicin)
 Decrease conjugation (Gilbert Syndrome, Criggler Najjar Syndrome)

Conjugated Hyperbilirubinemia
 Dubin-Johnson syndrome
 Rotor syndrome
Hepatocellular Jaundice
Acute or subacute hepatocellular injury
Viral hepatitis, alcohol, drugs, ischemic hepatitis, Wilson's disease

Chronic hepatocellular disease


Viral hepatitis, alcoholic, autoimmune hepatitis, Wilson’s, haemochromatosis, NASH,
alpha 1 antitrypsin deficiency.

Hepatic disorders with prominent cholestasis

 Diffuse infiltrative disorders (e.g. granulomatous disease, TB, sarcoidosis, lymphoma,


drugs) Amyloidosis, malignancy.
 Inflammation of intrahepatic bile ductules (PBC), Drugs (chloropromazine)
 Miscellaneous e.g. use of oestrogen & steroids, TPN, bacterial Infection.
Obstruction of The bile duct

 Benign----------Choledocholithiasis, pancreatitis
 Malignant----carcinoma gallbladder, periampullary carcinoma, cholangiocarcinoma,
Ca head of pancreas
Investigations

Serum Biochemical Tests:

Bilirubin:
The normal serum bilirubin is <1.5mg/dl of which <0.5% is conjugated.

 In haemolysis or genetic disorders e.g. Gilbert syndrome there is


unconjugated hyperbilirubinaemia (>90%).
 In hepatocellular jaundice >50% of bilirubin is conjugated.
 In obstructive jaundice the circulating bilirubin is mainly conjugated.
Enzymes raised in hepatocellular injury:

 Aminotransferases include ALT (located in cytosol) & AST (located in mitochondria & cytosol).

 ALT is found mainly in liver while AST is also found in other tissues such as skeletal & cardiac muscle.

 ALT is more specific than AST in detecting liver disease.

 AST & ALT are released following hepatocyte necrosis.

 A marked raise in transaminases > 1000 U/L, is seen in Autoimmune viral hepatitis, ischaemic
hepatitis & drug-induced liver disease.

 In alcoholic liver disease, the enzyme levels are rarely raised > 200-300 U/L, with AST:ALT ratio
>2:1.
Enzymes raised in cholestasis:

 Alkaline Phosphatase (ALP), gamma-glutamyl transpeptidase (GGT) & 5’-


nucleotidase (5’NT).

 ALP isoenzymes are also present in bone & placenta.

 Increase in ALP, GGT & 5’NT suggest hepatobiliary origin.

 GGT levels are often disproportionately elevated in alcoholic liver disease.


Albumin:

 Albumin is synthesized by liver & has a half-life of 15-20 days.

 Decreased level of albumin are seen in advanced hepatic cirrhosis &


signify severe hepatic dysfunction.

 Serum albumin usually remain normal in acute hepatitis; falling values in


this setting imply an unusual sever course.
Globulins:

 Non-specific diffuse elevation is common in CLD.

 There is a disproportionate elevation of IgG in autoimmune hepatitis, IgM in Primary


biliary cholangitis & IgA in alcoholic liver disease.
INR & Prothrombin time (PT):

 INR/PT is a valuable index of the ability of liver to synthesize vit. K-


dependent clotting factors.

 An increasing PT/INR implies relatively severe hepatocellular dysfunction.

 The PT/INR may be deranged in cholestasis as well, but this is due to the
malabsorption of vit. K & is rapidly corrected by parenteral administration of
vit K.
Other tests:

 Antimitochondrial antibody (AMA) for PBC

 Antinuclear factor (ANA), anti-smooth muscle antibody (ASMA) & anti-


liver kidney microsome (LKM) antibody seen in autoimmune hepatitis

 alpha-fetoprotien which is raised in HCC

 serum caeruloplasmin for Wilson disease


Imaging Procedures

 Radiological imaging is important for the diagnosis of a focal liver mass


or biliary disease. However, imaging plays little role in the evaluation of
diffuse hepatocellular e.g. hepatitis
Ultrasonography (US)

 It is a valuable but operator-dependent investigation.

 It has sensitivity of 55-91% & specificity of 82-95% for biliary obstruction.

 Although US may not detect stones in the extrahepatic bile duct, which
may be obscured by overlying gas, it reliably establishes the presence of
a dilated bile ducts

 Besides it can differentiate intrahepatic from extrahepatic cholestasis, US


can also detect the associated abnormalities such as portal hypertension,
focal lesions & fatty liver.
ERCP
 ERCP not only permits direct visualization of the biliary tree but also
allows therapeutic intervention e.g. removal of CBD stones or biliary
stenting.

 It is the gold standard test for the evaluation of extrahepatic biliary


disease causing jaundice.
PERCUTANEOUS TRANSHEPATIC CHOLANGIOGRAPHY

 IN PTC, direct contrast visualization of the biliary tree is obtained via a percutaneous
needle puncture of the liver. It is useful if there is high biliary obstruction e.g. a
tumour at the bifurcation of the hepatic ducts.

 It also permits therapeutic intervention such as stent insertion to bypass a ductal


malignancy.
MRCP
 MRCP is superior to US & CT in detecting biliary obstruction. It has a sensitivity of 82-100% &
a specificity of 92-98% to detect biliary obstruction.

CT Scan
 CT has a sensitivity of 63-96% & a specificity of 93-100% to detect biliary
obstruction.

 Non-calcified cholestrol gall stones can be easily missed on CT because they may
be isodense with bile.
LIVER BIOPSY
 It has relatively low risk, it is needed in only a minority of cases with
hepatic dysfunction.

 Major indications include


• chronic hepatitis
• cirrhosis
• unexplained liver enzyme abnormalities
• hepatosplenomegaly of unknown aetiology
• suspected infiltrative disorder
• suspected granulomatous disease.
Relative contraindications include a tendency for clinical bleeding,
• INR>1.5 or PT >3 sec above the control,
• severe thrombocytopenia &
• marked ascites.
Thank you…….

You might also like